Benign neoplasm: Scapula and long bones of upper limb

CD2_BENIGN_BONE_SCAPULA_LONG_UPPER

tongue neoplasm: A neoplasm (disease) that involves the tongue.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D16.0& Hospital discharge: ICD-9 — 2134 Hospital discharge: ICD-8 — 21303 Cause of death: ICD-10 — D16.0& Cause of death: ICD-9 — 2134 Cause of death: ICD-8 — 21303 2 out of 7 registries used, show all original rules.	419
4. Check minimum number of events None	419
5. Include endpoints None	419
6. Filter based on genotype QC (FinnGen only)	385

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D16
Name in latin: Neoplasma benignum scapulae sive ossium longorum membri superioris

NAME	CD2_BENIGN_BONE_SCAPULA_LONG_UPPER
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D160
HD_ICD_9	2134
HD_ICD_8	21303
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D160
COD_ICD_9	2134
COD_ICD_8	21303
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Scapula and long bones of upper limb based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	3001	1340	1651
Only index persons	2788	1256	1532
Unadjusted period prevalence (%)
Whole population	0.04	0.04	0.05
Only index persons	0.05	0.05	0.06
Median age at first event (years)
Whole population	28.48	34.17	23.81
Only index persons	27.91	34.14	22.80

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	385	202	183
Unadjusted period prevalence (%)	0.08	0.07	0.08
Median age at first event (years)	35.56	35.71	35.40

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
397: Matched controls
3970

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D16.0

ICD-10 Finland

Benign neoplasm: Scapula and long bones of upper limb

+∞

307.7

279

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

36.8

101.6

21303

ICD-8 Finland

Benign neoplasm of bone and cartilage, Ossium longorum extremitatis superioris et scapulae

+∞

93.5

NBR20

NOMESCO Finland

Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm

198.8

51.2

2134A

ICD-9 Finland

Benign neoplasm of bone and articular cartilage, Scapula and long bones of upper limb

+∞

34.9

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

10.2

33.2

D16.1

ICD-10 Finland

Benign neoplasm: Short bones of upper limb

96.4

25.0

9102

FHL

Trepanation or removal of the local bone process

31.1

22.2

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.0

17.4

151

D16.2

ICD-10 Finland

Benign neoplasm: Long bones of lower limb

23.1

17.1

NDR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of wrist or hand

14.0

14.9

NK6BN

NOMESCO Finland

Bone dynamic isotope examination

77.9

13.7

NGR20

NOMESCO Finland

Intralesional or marginal excision of tumor of knee or lower leg

61.7

10.7

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

33.5

10.4

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

5.0

10.1

NB6AA

NOMESCO Finland

Humerus X-ray examination

8.4

9.5

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

5.1

9.4

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.1

9.2

118

675

M47.9

ICD-10 Finland

Spondylosis, unspecified

4.9

8.7

NCR20

NOMESCO Finland

Incomplete excision of soft tissue tumour of elbow or forearm

81.6

7.4

GA1CG

NOMESCO Finland

Extensive MRI of chest

81.6

7.4

9101

FHL

Bone biopsy

+∞

7.3

NB4AA

NOMESCO Finland

Scapula X-ray examination

20.5

7.2

L08

ICPC

Shoulder symptom/complaint

1.9

6.9

101

599

NB1AD

NOMESCO Finland

Shoulder CT examination

6.9

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.7

6.8

139

N02AX02

ATC

tramadol; systemic, rectal

1.7

6.7

171

1201

NBR30

NOMESCO Finland

Extensive or radical excision of soft tissue tumour of shoulder or upper arm

+∞

6.3

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

5.9

6.2

A03FA02

ATC

cisapride; oral, rectal

2.8

6.2

111

M01AH05

ATC

etoricoxib; oral

1.7

6.0

256

2042

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

117

805

1.64

4.60

2.0

2.3

—

(3021788) Differential panel - Synovial fluid

3.29

4.38

1.7

1.3

—

(40768804) Tissue Pathology biopsy report

173

1356

1.49

3.66

2.2

2.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

189

1513

1.48

3.57

2.6

2.5

75.33

74.49

nmol/l

0.16

179

1385

(3006571) Granulocytes/Leukocytes in Synovial fluid

3.83

3.41

1.6

1.3

70.71

49.62

—

(3037522) Nuclear Ab [Titer] in Serum

508

1.61

3.28

1.6

1.3

375.00

554.56

titre

0.78

103

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

673

1.54

3.19

1.4

1.3

11.76

26.72

iu/ml

3.54

214

(3026493) Urate [Moles/volume] in Serum or Plasma

117

872

1.48

3.08

2.6

2.8

334.07

342.54

umol/l

0.44

107

780

(1616796) Gas panel - Central venous blood

2.65

3.08

4.2

3.3

—

(3044640) Blood type and Crossmatch panel - Blood

140

1089

1.44

2.94

2.1

2.3

—

(3044941) Cell count panel - Synovial fluid

2.83

2.84

1.5

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.51

2.81

1.5

2.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2.37

2.79

1.4

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

629

1.49

2.63

1.4

1.3

1.15

8.43

u/ml

3.90

243

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

2.78

2.57

1.1

1.4

0.59

0.51

nmol/l

0.47

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

5.06

2.41

3.8

6.6

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

285

2559

1.40

2.38

5.3

4.1

9.50

10.18

mm/h

0.53

257

2401

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.55

2.38

1.0

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

6.31

2.38

4.4

2.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

112

870

1.40

2.29

3.4

3.3

965.85

936.17

ng/l

0.04

731

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

5.61

2.22

1.4

2.4

141.40

145.33

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

644

1.43

2.16

1.5

1.7

398.52

29982480.13

pmol/l

0.72

557

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

170

1425

1.34

2.13

5.9

6.6

1.21

mmol/l

0.05

154

1322

(3012516) Albumin [Mass/volume] in Urine

125

1007

1.35

2.02

3.4

3.6

24.66

54.34

mg/l

2.85

672

(3005719) IgG [Mass/volume] in Serum or Plasma

292

1.57

1.98

1.6

2.4

10.02

10.43

g/l

0.33

271

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

185

1583

1.32

1.97

6.6

7.2

1.21

mmol/l

0.04

156

1381

(3020682) Albumin/Creatinine [Ratio] in Urine

127

1031

1.34

1.94

3.9

4.3

4.31

9.61

mg/mmol

2.34

668

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.22

1.89

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.22

1.89

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

2.07

1.88

1.2

1.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2.00

1.82

1.4

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

2.07

1.77

1.7

1.4

10626.00

13451.05

e6/l

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.37

1.75

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.37

1.75

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.37

1.75

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

3.37

1.75

1.0

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

2.53

1.75

3.3

1.9

84.50

90.71

—

(3015736) pH of Urine

169

1446

1.29

1.74

3.4

3.2

6.30

6.15

0.87

846

(3009261) Glucose [Presence] in Urine by Test strip

209

1844

1.28

1.68

3.9

3.6

0.00

0.83

estimate

0.50

360

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

238

1.56

1.67

2.9

2.5

5.13

8.96

ug/l

1.45

214

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

282

2587

1.31

1.66

8.0

8.1

74.90

77.25

u/l

0.61

274

2469

(3024263) Appearance of Synovial fluid

3.60

1.62

1.8

1.9

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

135

1131

1.29

1.61

2.3

3.3

2.35

2.36

mmol/l

0.54

121

1037

(3000494) Fungus identified in Specimen by Culture

436

1.41

1.60

1.4

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

218

1943

1.27

1.57

4.5

5.0

6.30

6.62

mmol/l

1.82

208

1832

(3020650) Glucose [Presence] in Urine

3.36

1.53

2.4

1.3

0.00

estimate

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.62

1.52

1.0

1.1

—

(3035715) Granulocytes [#/volume] in Blood

2.10

1.50

2.7

3.7

3.55

4.56

e9/l

1.11

(3022145) Colonoscopy Study observation

398

1.41

1.49

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

106

868

1.30

1.49

4.6

5.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

2.46

1.49

1.1

1.4

—

(3019060) Gas panel - Arterial blood

172

1.61

1.47

2.9

7.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

254

1.50

1.47

1.4

1.3

572.10

321.37

u/ml

0.25

241

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.53

1.46

1.1

1.5

—

(3002256) Pathology report gross observation

444

1.39

1.45

1.4

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

205

1826

1.25

1.44

4.0

3.5

0.02

0.00

estimate

0.49

385

(3019225) pH of Specimen

272

1.48

1.44

4.1

4.4

7.31

7.32

0.13

196

(3023103) Potassium [Moles/volume] in Serum or Plasma

358

3427

1.45

1.42

17.3

16.1

3.96

3.97

mmol/l

0.18

342

3357

(4062490) Immunoglobulin typing, IgG

2.28

1.41

1.0

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

103

847

1.29

1.40

2.1

2.74

2.80

mg/l

0.10

748

(40768800) Prostate Pathology biopsy report

2.03

1.39

1.8

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.86

1.37

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.86

1.37

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.63

1.37

1.0

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

242

1.49

1.35

3.5

4.1

1.21

1.22

mmol/l

0.44

213

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

345

1.41

1.34

9.6

6.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

2.00

1.34

1.0

1.1

1.19

4.40

u/ml

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

1.32

0.0

13.8

—

822.61

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

357

3424

1.42

1.31

17.1

15.9

139.83

139.73

mmol/l

0.37

341

3364

(3042631) Mycobacterium sp identified in Specimen

2.12

1.31

3.6

3.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.52

1.31

1.0

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

2.80

1.29

1.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2.07

1.27

1.1

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1.85

1.27

1.1

1.0

7.22

6.20

u/ml

—

(40768443) Skin Pathology biopsy report

139

1.62

1.26

1.2

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

161

1414

1.23

1.24

4.0

4.9

36.48

36.51

g/l

0.02

154

1339

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1.93

1.24

1.0

1.1

13.12

1.43

u/ml

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.19

1.22

1.8

1.4

19.06

30.29

ng/l

—

(44813793) Dust mix specific IgE antibody measurement

2.65

1.22

1.0

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

206

1.49

1.21

4.9

10.1

92.91

93.65

0.16

206

(3021601) Nitrite [Presence] in Urine by Test strip

201

1810

1.22

1.21

4.0

3.5

0.00

estimate

-0.00

386

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.90

1.19

1.0

1.1

—

(40768797) Stomach Pathology biopsy report

460

1.33

1.18

1.2

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

198

1784

1.22

1.17

4.9

6.6

10.55

11.13

umol/l

0.55

187

1705

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1.83

1.16

1.1

0.77

1.84

u/ml

—

(3045142) Bone marrow Pathology biopsy report

2.07

1.16

1.0

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

2.52

1.15

2.2

3.3

110.40

91.80

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.52

1.15

1.0

1.6

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

2.52

1.15

3.6

4.3

80.20

156.65

nmol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

356

3427

1.38

1.14

15.9

14.2

24.12

22.03

mg/l

0.46

288

2778

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1.73

1.13

1.1

0.34

1.71

u/ml

—

(21494815) CD4 cells/Lymphocytes in Specimen

2.36

1.13

2.0

37.24

39.40

—

(44806420) Estimation of glomerular filtration rate

2.02

1.12

2.6

2.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1.81

1.12

1.3

1.4

0.95

0.90

nmol/l

0.11

(3009508) Creatinine [Moles/volume] in Urine

130

1129

1.23

1.09

3.3

3.4

8.22

8.16

mmol/l

0.04

108

973

(3008898) HLA-B27 [Presence]

161

1.52

1.09

1.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

341

1.36

1.09

4.5

9.5

5.34

5.17

kpa

0.46

329

(3027801) Oxygen [Partial pressure] in Arterial blood

341

1.36

1.09

4.5

9.5

12.45

12.21

kpa

0.10

330

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.40

1.09

1.0

1.6

—

(40761536) Microorganisms panel - Urine sediment

280

1.39

1.09

4.6

3.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.73

1.06

1.4

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1.82

1.05

1.8

3.4

5.06

8.81

pmol/l

1.74

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

308

1.37

1.05

3.8

3.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.69

1.05

2.9

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.66

1.05

1.1

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

122

1.59

1.04

2.1

1.3

—

(21494434) Karyotype in Bone marrow

2.29

1.03

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

2.29

1.03

1.6

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

178

1603

1.20

1.02

2.7

—

estimate

—

(3016502) Oxygen saturation in Arterial blood

310

1.36

1.02

4.4

10.1

94.26

95.57

0.42

301

(3029937) Albumin [Presence] in Urine by Test strip

116

1004

1.22

1.00

4.5

3.7

0.05

0.02

estimate

0.30

369

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

382

1.32

1.00

4.1

4.5

32.33

31.30

0.21

263

(3032080) INR in Blood by Coagulation assay

162

1450

1.20

0.99

16.0

11.3

1.22

1.17

inr

0.63

137

1193

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

124

1.56

0.98

2.3

1.6

1.10

1.19

g/l

0.57

119

(3017817) Protein [Mass] in Urine collected for unspecified duration

2.19

0.98

2.4

3.7

260.40

965.57

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.82

0.97

1.2

—

(3018418) pH of Serum or Plasma

112

970

1.22

0.96

4.2

7.40

0.03

689

(3026008) Bacteria identified in Urine by Culture

105

905

1.22

0.95

3.5

2.8

—

(3019977) pH of Arterial blood

341

1.33

0.94

4.5

9.6

7.40

7.41

0.54

193

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

2.24

0.94

1.0

1.6

13.62

10.88

umol/l

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.24

0.94

1.7

1.1

129.33

107.22

pmol/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

110

1.57

0.92

1.0

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

298

1.34

0.92

4.5

10.2

128.38

121.62

g/l

1.61

290

(3001019) Free T4 and TSH panel - Serum or Plasma

218

0.63

0.91

1.3

1.7

—

(4024509) Urine culture

127

1.52

0.90

2.0

1.8

—

(40758558) Short blood count panel - Blood

117

1024

1.20

0.90

5.6

6.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1.71

0.89

1.1

1.0

1.26

3.83

u/ml

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

371

3615

1.40

0.89

19.5

17.9

76.21

umol/l

0.00

363

3577

(3035933) Granulocytes/Leukocytes in Blood

1.67

0.89

3.2

3.5

57.15

59.79

0.35

(3027273) Bicarbonate [Moles/volume] in Venous blood

140

0.56

0.84

3.9

3.4

28.60

24.66

mmol/l

—

135

(3021447) Carbon dioxide [Partial pressure] in Venous blood

317

0.71

0.84

3.4

3.5

6.03

5.74

kpa

0.46

307

(3023419) Bacteria identified in Sputum by Culture

1.75

0.83

1.9

2.4

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

1.89

0.82

1.0

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.00

0.79

0.0

8.0

—

38.88

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

1.83

0.79

1.0

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.68

0.79

1.1

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.68

0.79

1.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

268

2535

1.18

0.79

3.5

3.3

43.84

43.87

u/l

0.00

255

2429

(3012544) pH of Venous blood

313

0.72

0.79

3.3

3.5

7.38

0.12

171

(3045424) Erythrocytes [Presence] in Urine

166

1.41

0.77

2.5

2.2

0.00

estimate

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

107

1.52

0.77

1.5

1.2

—

2.52

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1.78

0.76

3.7

4.2

—

51.21

—

(3023420) DNA double strand Ab [Units/volume] in Serum

158

1.42

0.76

1.9

2.5

4.00

6.20

iu/ml

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

172

0.63

0.75

3.5

2.4

0.56

0.61

0.29

172

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.10

0.74

1.0

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

566

1.22

0.74

2.7

2.8

1.36

0.85

e6/l

0.24

297

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

1.86

0.74

2.0

3.7

2.83

7.29

nmol/l

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

1.93

0.71

1.2

1.7

—

523.00

—

(3028026) IgM [Mass/volume] in Serum or Plasma

231

1.32

0.70

1.8

1.5

2.90

1.15

g/l

0.61

217

(42870588) Differential panel, method unspecified - Blood

130

1175

1.16

0.67

6.1

5.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

101

895

1.17

0.67

1.7

1.6

21.00

21.35

nmol/l

0.09

775

(3001122) Ferritin [Mass/volume] in Serum or Plasma

184

1708

1.14

0.65

3.1

3.0

113.87

105.11

ug/l

0.30

168

1624

(3010838) Calcium [Moles/time] in 24 hour Urine

1.63

0.65

2.4

2.0

5.98

5.18

mmol/24h

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

380

1.24

0.64

1.7

1.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

417

1.23

0.64

4.7

6.3

1.00

1.05

mmol/l

0.73

389

(3007164) IgA [Mass/volume] in Serum or Plasma

832

1.17

0.64

1.4

2.20

2.40

g/l

0.61

530

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

614

1.19

0.63

3.4

3.8

1757.02

414.14

ng/l

0.41

442

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

138

1259

1.15

0.63

4.4

3.5

33.72

83.54

ng/l

0.50

814

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

103

0.58

0.63

1.2

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

153

1406

1.14

0.63

2.2

2.0

101.84

96.11

pmol/l

0.62

758

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.56

0.62

1.2

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.67

0.61

2.2

3.0

—

(3048689) Calprotectin [Mass/mass] in Stool

494

1.20

0.61

2.1

2.4

89.75

108.58

ug/g

0.41

397

(44816559) Phosphatidylethanol [Mass/volume] in Blood

192

1.32

0.61

2.0

1.5

0.56

0.31

mg/l

0.75

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

335

3252

1.19

0.61

5.1

4.6

5.95

5.88

mmol/l

0.43

311

3045

(4198724) Urine methamphetamine measurement

0.00

0.60

0.0

2.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

219

1.30

0.60

1.3

—

39.00

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

278

2664

1.15

0.59

4.6

4.3

14.51

14.58

pmol/l

0.19

260

2476

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.58

0.0

1.1

—

(40761511) CBC panel - Blood by Automated count

363

3554

1.25

0.57

13.8

12.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

783

1.16

0.56

1.7

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

322

1.23

0.56

1.4

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.63

0.56

3.0

4.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

170

0.70

0.54

1.0

1.1

0.84

0.91

g/l

0.52

170

(3002582) Erythrocytes [#/volume] in Urine

119

1085

1.14

0.54

3.0

3.3

25.84

111.08

e6/l

0.80

836

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

169

1.32

0.54

1.1

2.1

3.15

2.88

mg/l

0.09

130

(3024354) Oxygen [Partial pressure] in Venous blood

271

0.76

0.54

3.1

2.7

4.68

4.53

kpa

0.12

262

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

529

1.18

0.54

2.8

3.0

2.37

2.19

e6/l

0.05

258

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.55

0.53

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

135

0.66

0.52

3.0

8.0

1.94

1.57

—

123

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.51

0.52

1.0

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

171

1.30

0.51

5.5

12.1

16.37

15.88

0.62

162

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.39

0.51

1.1

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.57

0.49

1.0

1.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

507

1.17

0.47

1.9

1.6

1165.52

1158.56

nmol/l

0.02

390

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

165

0.72

0.47

1.0

1.1

1.61

1.55

g/l

0.22

165

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

395

1.19

0.46

1.7

1.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

119

0.67

0.46

3.0

8.8

0.65

0.92

—

107

(3050129) First trimester maternal screen panel - Serum or Plasma

138

1.32

0.46

1.2

1.4

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

120

0.66

0.46

2.8

1.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

326

3178

1.14

0.45

5.5

5.2

1.77

1.86

mu/l

0.95

303

2986

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1.39

0.42

1.5

1.2

—

60.09

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

140

1.30

0.42

2.7

2.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

140

1.30

0.42

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

113

1043

1.12

0.42

5.9

5.0

2.06

2.57

ug/l

0.46

107

952

(3028707) Methadone [Presence] in Urine by Screen method

0.63

0.42

1.3

1.8

—

(40768793) Breast Pathology biopsy report

0.63

0.42

1.7

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1.37

0.42

2.9

2.1

3.16

5.37

iu/l

—

(3022948) Iron [Moles/volume] in Serum or Plasma

523

1.15

0.41

2.0

2.5

14.78

13.68

umol/l

0.47

494

(3007461) Platelets [#/volume] in Blood

379

3743

1.28

0.41

23.6

21.8

257.15

251.69

e9/l

1.01

368

3691

(3028433) Virus identified in Specimen by Culture

0.00

0.41

0.0

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

667

1.13

0.41

1.6

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.41

0.0

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

327

3194

1.13

0.41

5.9

38.59

38.90

mmol/mol

0.26

307

3045

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

0.40

0.0

1.4

—

66.28

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

803

1.12

0.40

1.9

2.0

—

(3030467) Casts [#/volume] in Urine by Automated count

102

939

1.12

0.40

3.0

3.1

0.36

0.34

e6/l

0.06

698

(3024731) MCV [Entitic mean volume] in Red Blood Cells

379

3744

1.27

0.40

23.6

21.7

90.38

90.68

0.72

373

3716

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.40

0.0

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

563

1.14

0.40

2.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1.43

0.39

1.2

—

(3018095) Leukocytes [#/volume] in Urine

135

1264

1.10

0.39

3.5

3.9

23.93

88.56

e6/l

1.65

892

(3035941) MCH [Entitic mass]

379

3745

1.27

0.39

23.6

21.7

30.09

30.28

1.44

373

3716

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

379

3745

1.27

0.39

23.9

22.1

52.17

41.00

0.51

373

3715

(3026361) Erythrocytes [#/volume] in Blood

379

3745

1.27

0.39

23.6

21.8

4.58

4.57

e12/l

0.14

367

3685

(3020779) Urea [Moles/volume] in Serum or Plasma

271

1.20

0.38

6.6

8.0

7.73

9.13

mmol/l

0.74

263

(36660697) Celiac disease serology panel - Serum

318

1.18

0.38

1.3

1.2

—

(3010813) Leukocytes [#/volume] in Blood

379

3746

1.26

0.38

23.7

21.8

6.57

6.68

e9/l

0.53

367

3685

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.36

0.37

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

519

1.14

0.36

2.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1.37

0.36

2.2

2.6

10.13

131.81

ug/min

—

(1761868) Lipid panel - Serum or Plasma

146

1545

0.91

0.36

2.8

3.0

—

(3004616) Nuclear Ab [Presence] in Serum

1.47

0.36

2.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

108

1.31

0.35

1.6

1.3

217.73

325.16

ug/g

—

(3000963) Hemoglobin [Mass/volume] in Blood

379

3748

1.25

0.35

23.9

21.9

137.59

137.48

g/l

0.05

373

3719

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

100

927

1.11

0.35

1.4

1.3

1.56

1.25

u/ml

0.18

263

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1.40

0.35

1.2

263.33

234.92

pmol/l

—

(3022621) pH of Urine by Test strip

286

0.83

0.35

1.9

2.1

5.81

6.16

1.97

187

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.37

0.34

1.2

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.37

0.34

1.2

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

154

1.25

0.34

2.7

2.4

8333.05

5640.89

u/l

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.34

0.34

1.2

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.34

0.34

1.2

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.34

0.34

1.2

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

745

1.11

0.33

2.5

2.7

3.25

5.22

e6/l

1.49

684

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1.31

0.33

1.2

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.31

0.33

1.2

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

533

1.13

0.33

1.8

1.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

114

1068

1.09

0.32

2.4

2.5

56.31

64.04

u/l

0.66

105

1004

(3008152) Bicarbonate [Moles/volume] in Arterial blood

185

1.20

0.30

4.1

9.4

25.60

24.59

mmol/l

0.74

175

(3023368) Bacteria identified in Blood by Culture

877

1.09

0.29

4.7

4.4

—

(3000991) Gas panel - Venous blood

270

1.16

0.29

5.6

8.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

162

0.80

0.29

1.2

1.6

—

(21494755) Public health laboratory ask at order entry panel

452

1.12

0.28

1.2

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.30

0.28

1.4

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

119

0.75

0.27

1.7

1.8

—

(3001604) Monocytes [#/volume] in Blood

188

1810

1.07

0.27

7.1

6.3

0.59

0.57

e9/l

0.70

172

1563

(3041096) Erythrocytes [Presence] in Urine by Automated

110

1038

1.08

0.27

3.5

2.9

0.08

estimate

0.01

319

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

150

1.21

0.27

1.1

1.5

330.67

245.62

miu/ml

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.70

0.26

4.8

3.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

114

1.24

0.25

1.2

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.20

0.25

1.0

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.73

0.24

1.0

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.70

0.24

1.0

1.3

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

334

3291

1.09

0.24

14.9

13.5

86.25

86.05

ml/min/173m2

0.06

294

3021

(3006315) Basophils [#/volume] in Blood

188

1817

1.07

0.24

7.1

6.3

0.04

e9/l

0.39

168

1570

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

115

1.23

0.24

1.2

1.5

1.54

0.96

ratio

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

115

1.23

0.24

1.2

1.5

1.10

1.22

ratio

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

171

1.18

0.23

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

146

1400

1.07

0.23

4.2

3.4

0.08

0.01

estimate

0.40

336

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

106

1.23

0.23

2.0

2.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.32

0.23

1.2

122.58

173.49

pmol/l

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.29

0.23

1.2

—

(3023410) Appearance of Cerebral spinal fluid

1.25

0.22

1.0

1.3

—

(3021589) Normoblasts [#/volume] in Blood

156

1619

0.94

0.22

12.6

10.8

0.00

e9/l

0.60

131

1326

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

277

1.13

0.22

1.8

2.7

82.93

69.17

ml/min/173m2

1.15

127

(3013650) Neutrophils [#/volume] in Blood by Automated count

207

2011

1.06

0.22

7.8

10.1

4.15

4.02

e9/l

0.38

183

1758

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

418

0.90

0.21

1.6

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

15.31

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

0.80

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.24

0.21

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.3

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

47.95

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

0.21

0.0

1.5

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.21

0.0

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

155

0.83

0.20

1.0

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

2.6

—

0.60

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.20

0.0

3.6

—

4.76

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.20

0.0

3.6

—

10.86

—

(3002030) Lymphocytes/Leukocytes in Blood

167

1725

0.94

0.20

7.2

6.3

28.10

28.20

0.04

161

1646

(3013139) Helicobacter pylori Ag [Presence] in Stool

239

0.87

0.20

1.2

—

(3002179) Metamyelocytes/Leukocytes in Blood

289

1.12

0.19

4.3

4.7

0.71

0.55

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

619

1.08

0.19

2.4

2.8

2.42

2.44

mmol/l

1.63

547

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1.13

0.18

1.0

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

807

1.07

0.18

2.0

1.7

0.67

1.27

mg/l

3.48

620

(3019150) Specific gravity of Urine by Refractometry

802

0.94

0.18

4.5

3.6

1.02

kg/l

0.12

533

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

121

0.82

0.18

1.7

2.0

—

(3037756) Immunofixation for Serum or Plasma

1.17

0.18

1.9

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.13

0.17

1.0

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.13

0.17

1.0

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

194

0.87

0.17

1.0

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

263

1.11

0.17

2.3

2.8

76.65

71.86

e9/l

0.27

187

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.72

0.17

1.4

1.5

68.68

53.25

ug/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

247

2423

1.05

0.17

3.3

3.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

517

1.07

0.16

1.6

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.77

0.15

2.8

5.9

—

178.50

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

275

1.10

0.15

1.5

1.4

—

(4035726) Immunohistochemistry procedure

285

0.91

0.14

1.6

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.83

0.14

1.4

1.6

—

(1002224) Polysomnography panel

232

0.90

0.13

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

570

1.06

0.13

1.7

1.6

—

(3003694) ABO and Rh group [Type] in Blood

102

1056

0.95

0.13

1.6

1.5

—

(3022313) Gas panel - Capillary blood

148

0.87

0.12

3.9

3.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

123

1.14

0.12

1.3

1.6

50.22

56.56

ug/l

0.28

103

(3019832) Treponema pallidum Ab [Presence] in Serum

444

1.07

0.12

1.9

1.8

—

(3016879) Cocaine [Presence] in Urine

189

0.89

0.12

1.2

1.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

137

0.87

0.12

1.8

1.9

1.37

1.41

g/l

0.06

120

(3019198) Lymphocytes [#/volume] in Blood

190

1863

1.04

0.12

7.1

6.3

1.83

1.96

e9/l

0.90

175

1649

(3025941) Bacteria identified in Stool by Culture

191

1.11

0.12

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

201

1.10

0.11

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

652

1.05

0.11

3.4

3.0

0.79

0.73

ug/l

0.22

385

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

126

0.87

0.11

1.3

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

495

1.06

0.11

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

115

1.13

0.10

1.2

1.5

0.77

1.07

ratio

—

(3004809) Band form neutrophils/Leukocytes in Blood

1.09

0.09

2.4

3.4

1.60

1.20

—

(3004588) Protein electrophoresis panel - Serum or Plasma

194

1.09

0.09

2.8

2.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

835

1.04

0.09

4.3

17.89

21.71

1.92

363

(3042936) Bacteria identified in Isolate by Culture

479

1.05

0.09

2.8

2.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

224

1.08

0.08

1.3

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.79

0.08

2.4

3.2

—

5517.00

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

439

0.95

0.08

5.1

6.9

103.14

104.22

mmol/l

0.88

439

(3028300) Cannabinoids [Presence] in Urine

205

0.92

0.08

1.2

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.06

0.08

2.3

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

343

3450

0.96

0.08

5.4

2.83

2.78

mmol/l

0.52

323

3265

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

343

3410

1.04

0.07

5.1

4.9

4.65

4.68

mmol/l

0.26

320

3238

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.85

0.07

1.0

1.5

—

(3011288) Drugs identified in Urine by Screen method Nominal

137

1.10

0.07

1.4

1.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.08

0.07

1.3

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

1.04

0.07

1.1

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

417

0.95

0.07

2.0

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.86

0.07

1.0

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

177

1.08

0.06

1.7

—

(3045414) Leukocytes [Presence] in Urine

305

1.05

0.06

2.4

2.1

0.11

0.00

estimate

—

(4094501) Cardiovascular stress test using bicycle ergometer

101

0.89

0.06

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

101

0.89

0.06

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

101

0.89

0.06

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

151

1490

1.02

0.05

1.9

2.0

1.38

1.39

mmol/l

0.07

127

1281

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

323

3247

0.97

0.05

4.3

4.1

1.30

1.29

mmol/l

0.12

305

3052

(3022096) Basophils/Leukocytes in Blood

165

1670

0.98

0.05

7.2

6.3

0.64

0.68

0.47

156

1570

(3021440) Promyelocytes/Leukocytes in Blood

287

1.05

0.05

4.8

4.9

0.40

0.16

—

(3019069) Monocytes/Leukocytes in Blood

166

1679

0.98

0.05

7.2

6.4

9.00

8.71

0.76

157

1589

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

121

1.08

0.03

1.5

1.2

—

(3006504) Eosinophils/Leukocytes in Blood

166

1673

0.99

0.03

7.1

6.3

2.89

2.84

0.12

158

1580

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

118

0.93

0.03

3.8

3.6

24.81

24.95

mmol/l

0.07

113

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

361

3619

0.97

0.02

12.0

11.3

28.14

27.62

u/l

0.21

352

3549

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

359

0.97

0.02

1.4

1.8

3.74

3.52

mmol/l

0.45

265

(3005033) Fetal Nuchal fold Thickness US

1.08

0.02

1.3

1.5

1.23

1.33

—

(3003327) Ova and parasites identified in Stool by Light microscopy

127

0.94

0.01

2.5

1.5

—

(3013115) Eosinophils [#/volume] in Blood

189

1881

1.01

0.01

7.2

6.6

0.18

0.19

e9/l

0.16

170

1653

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

257

0.97

0.01

2.4

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

306

0.98

0.00

3.0

2.2

—

(3000492) Spirometry study

406

0.98

0.00

1.5

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

486

0.99

0.00

1.7

2.0

3.63

3.53

ratio

0.19

393

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.02

0.00

1.4

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

102

0.98

0.00

1.1

1.2

—

(4034850) Laboratory test

112

0.98

0.00

27.5

9.5

—

(3049717) Cytology report of Urine Cyto stain

112

0.98

0.00

2.0

2.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

118

1.02

0.00

1.8

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

272

0.99

0.00

1.1

1.3

58.08

145.87

u/ml

—

111

(3026782) Osmolality of Urine

642

1.00

0.00

2.7

564.57

543.59

mosm/kgh2o

0.30

563

(3000764) Benzodiazepines [Presence] in Urine

201

0.99

0.00

1.2

1.7

—

(3027944) Amphetamines [Presence] in Urine

203

0.98

0.00

1.2

1.7

—

(3017181) Myelocytes/Leukocytes in Blood

307

1.01

0.00

4.8

4.7

1.00

0.91

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

115

1.04

0.00

2.5

1.8

1.54

1.35

ug/l

0.06

103

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

154

0.97

0.00

1.3

1.8

—

(3027008) Opiates [Presence] in Urine

204

0.98

0.00

1.2

1.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.0

1.4

—

6.20

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

2.6

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

0.00

0.0

1.8

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

52.40

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.6

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.0

6.2

—

7.10

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

0.0

1.6

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

0.0

3.6

—

67.04

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

0.00

0.0

1.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

1.08

—

(3000285) Sodium [Moles/volume] in Blood

0.00

-0.00

0.0

1.0

—

139.00

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

0.94

-0.00

1.3

1.2

3.41

3.66

mmol/l

—

(3044007) Cell count panel - Peritoneal fluid

0.00

-0.00

0.0

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

53.33

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.94

-0.00

1.2

1.3

465.11

463.76

mg/l

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.91

-0.00

1.0

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

4.61

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.00

-0.00

0.0

3.1

—

8106.78

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.98

-0.00

1.5

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.91

-0.00

1.0

1.2

—

5.57

—

(3024932) HLA-DR beta [Type]

0.00

-0.00

0.0

1.3

—

(3024471) HLA-A [Type]

0.00

-0.00

0.0

1.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

-0.00

0.0

1.9

—

1.19

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

340

3400

1.00

-0.00

4.9

4.8

1.41

1.44

mmol/l

0.95

320

3212

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.8

—

1.20

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.96

-0.00

1.2

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.96

-0.00

1.0

1.3

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

-0.00

0.0

4.5

—

10.17

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.91

-0.00

1.1

1.6

—

(3013727) Leukocytes other/Leukocytes in Blood

0.00

-0.00

0.0

5.1

—

45.39

—

(3019174) dRVVT (LA screen)

0.00

-0.00

0.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

1.95

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.95

-0.00

1.0

1.5

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

0.00

-0.00

0.0

2.2

—

3.17

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

79.08

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

53.31

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.91

-0.00

1.1

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

-0.00

0.0

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

-0.00

0.0

1.3

—

(3033799) Differential panel - Peritoneal fluid

0.00

-0.00

0.0

1.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_BONE_SCAPULA_LONG_UPPER and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_BONE_SCAPULA_LONG_UPPER	1.04 [0.75, 1.44]	0.814
Birth year	0.993 [0.98, 1.0]	0.1

During the follow-up period (1.1.1998 — 31.12.2019), 53 out of 841 females with CD2_BENIGN_BONE_SCAPULA_LONG_UPPER died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_BONE_SCAPULA_LONG_UPPER	0.846 [0.65, 1.1]	0.217
Birth year	0.987 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 69 out of 986 males with CD2_BENIGN_BONE_SCAPULA_LONG_UPPER died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_BONE_SCAPULA_LONG_UPPER.

N-year risk	Females	Males
1	0.075%	0.198%
5	0.646%	1.007%
10	1.443%	2.695%
15	2.829%	5.179%
20	5.114%	8.344%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_BONE_SCAPULA_LONG_UPPER – Benign neoplasm: Scapula and long bones of upper limb

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Scapula and long bones of upper limb

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints